Deputy Chief Counsel Masoudi Will Succeed Troy In Acting Capacity
This article was originally published in The Rose Sheet
Executive Summary
Gerald Masoudi will be FDA's acting chief counsel after Daniel Troy departs Nov. 24
You may also be interested in...
FDA fills top attorney post
Former Department of Justice attorney Sheldon Bradshaw will serve as the new FDA Chief Counsel, effective April 18. The agency announced Bradshaw would replace Dan Troy, who joined Sidley Austin Brown & Wood in January, on April 4. Bradshaw has worked at the DoJ Civil Rights Division, where he was the Principal Deputy Assistant Attorney General. Before that, he was Deputy Assistant Attorney General in the DoJ Office of Legal Counsel. Gerald Masoudi, who joined FDA's Office of Chief Counsel as Deputy Chief Counsel in November, has temporarily filled the position since Troy's resignation (1"The Rose Sheet" Nov. 22, 2004, p. 8). Masoudi said he will remain at the office, returning to his post as deputy to Bradshaw...
FDA fills top attorney post
Former Department of Justice attorney Sheldon Bradshaw will serve as the new FDA Chief Counsel, effective April 18. The agency announced Bradshaw would replace Dan Troy, who joined Sidley Austin Brown & Wood in January, on April 4. Bradshaw has worked at the DoJ Civil Rights Division, where he was the Principal Deputy Assistant Attorney General. Before that, he was Deputy Assistant Attorney General in the DoJ Office of Legal Counsel. Gerald Masoudi, who joined FDA's Office of Chief Counsel as Deputy Chief Counsel in November, has temporarily filled the position since Troy's resignation (1"The Rose Sheet" Nov. 22, 2004, p. 8). Masoudi said he will remain at the office, returning to his post as deputy to Bradshaw...
Meet Masoudi: Deputy Counsel Brings Antitrust Experience To FDA
FDA Deputy Chief Counsel Gerald Masoudi can be expected to reinforce the agency's aggressive stance toward product liability suits that encroach on its regulatory authority